We hypothesized that DKO could serve as a more immunogenic candidate TB vaccine compared to BCG due to its retention of the RD1 region, which encodes six major immunogenic proteins, including CFP-10 and ESAT-6. The gene discussed is PDE6B; the disease is tuberculosis.